5-year outcome of initial treatment with ranibizumab monotherapy for polypoidal choroidal vasculopathy with good visual acuity

被引：0
|
作者：
Kohno, Takeya [1 ]
Yamamoto, Manabu [1 ]
Tamachi, Tomoko [1 ]
Asai, Jyunji [1 ]
Oishi, Natsuko [1 ]
Ataka, Shinsuke [1 ]
Yasui, Ayako [1 ]
Cho, Akira [2 ]
Hirabayashi, Michiko [2 ]
Shiraki, Kunihiko [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Ophthalmol & Visual Sci, Osaka, Japan
[2] Shiraniwa Hosp, Ikoma, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
880
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Treatment of Polypoidal Choroidal Vasculopathy With Photodynamic Therapy Combined With Intravitreal Injections of Ranibizumab
    Tomita, Kaoruko
    Tsujikawa, Akitaka
    Yamashiro, Kenji
    Ooto, Sotaro
    Tamura, Hiroshi
    Otani, Atsushi
    Nakayama, Yoshihito
    Yoshimura, Nagahisa
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (01) : 68 - 80
  • [42] Visual outcomes of polypoidal choroidal vasculopathy treated with intravitreal ranibizumab with or without photodynamic therapy
    Tan, Colin S.
    Ngo, Wei Kiong
    Lim, Louis W.
    ACTA OPHTHALMOLOGICA, 2018, 96 (02) : e254 - e255
  • [43] Factors influencing visual outcome of polypoidal choroidal vasculopathy one year after photodynamic therapy
    Ryusaburo Mori
    Mitsuko Yuzawa
    Zeon Lee
    Miho Haruyama
    Eriko Akaza
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 1233 - 1239
  • [44] Cost-effectiveness of Intravitreal Ranibizumab With Verteporfin Photodynamic Therapy Compared With Ranibizumab Monotherapy for Patients With Polypoidal Choroidal Vasculopathy
    Doble, Brett
    Finkelstein, Eric Andrew
    Tian, Yubing
    Saxena, Nakul
    Patil, Shiva
    Wong, Tien Yin
    Cheung, Chui Ming Gemmy
    JAMA OPHTHALMOLOGY, 2020, 138 (03) : 251 - 259
  • [45] INTRAVITREAL RANIBIZUMAB WITH OR WITHOUT PHOTODYNAMIC THERAPY FOR THE TREATMENT OF SYMPTOMATIC POLYPOIDAL CHOROIDAL VASCULOPATHY
    Lai, Timothy Y. Y.
    Lee, Gary K. Y.
    Luk, Fiona O. J.
    Lam, Dennis S. C.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (08): : 1581 - 1588
  • [46] EFFICACY OF AFLIBERCEPT IN JAPANESE PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY INSENSITIVE TO RANIBIZUMAB TREATMENT
    Hirakata, Toshiaki
    Nishikawa, Yuko
    Fujinami, Kaoru
    Watanabe, Ken
    Tsunoda, Kazushige
    Noda, Toru
    Akiyama, Kunihiko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [47] Polypoidal Choroidal Vasculopathy Exudation and Hemorrhage: Results of Monthly Ranibizumab Therapy at One Year
    Kokame, Gregg T.
    Yeung, Ling
    Teramoto, Kyla
    Lai, James C.
    Wee, Raymond
    OPHTHALMOLOGICA, 2014, 231 (02) : 94 - 102
  • [48] Prognostic factors of 2-year outcomes of ranibizumab therapy for polypoidal choroidal vasculopathy
    Hikichi, Taiichi
    Kitamei, Hirokuni
    Shioya, Shoko
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (06) : 817 - 822
  • [49] Long-term outcome of intravitreal ranibizumab treatment, compared with photodynamic therapy, in patients with polypoidal choroidal vasculopathy
    Inoue, M.
    Arakawa, A.
    Yamane, S.
    Kadonosono, K.
    EYE, 2013, 27 (09) : 1013 - 1020
  • [50] Long-term outcome of intravitreal ranibizumab treatment, compared with photodynamic therapy, in patients with polypoidal choroidal vasculopathy
    M Inoue
    A Arakawa
    S Yamane
    K Kadonosono
    Eye, 2013, 27 : 1013 - 1021
12345